Source memory in rats is impaired by an NMDA receptor antagonist but not by PSD95-nNOS protein-protein interaction inhibitors

Behavioural Brain Research
Alexandra E SmithJonathon D Crystal

Abstract

Limitations of preclinical models of human memory contribute to the pervasive view that rodent models do not adequately predict therapeutic efficacy in producing cognitive impairments or improvements in humans. We used a source-memory model (i.e., a representation of the origin of information) we developed for use in rats to evaluate possible drug-induced impairments of both spatial memory and higher order memory functions in the same task. Memory impairment represents a major barrier to use of NMDAR antagonists as pharmacotherapies. The scaffolding protein postsynaptic density 95kDa (PSD95) links NMDARs to the neuronal enzyme nitric oxide synthase (nNOS), which catalyzes production of the signaling molecule nitric oxide (NO). Therefore, interrupting PSD95-nNOS protein-protein interactions downstream of NMDARs represents a novel therapeutic strategy to interrupt NMDAR-dependent NO signaling while bypassing unwanted side effects of NMDAR antagonists. We hypothesized that the NMDAR antagonist MK-801 would impair source memory. We also hypothesized that PSD95-nNOS inhibitors (IC87201 and ZL006) would lack the profile of cognitive impairment associated with global NMDAR antagonists. IC87201 and ZL006 suppressed NMDA-stimulated form...Continue Reading

References

Dec 1, 1991·Psychology and Aging·D L SchacterM Valdiserri
Apr 1, 1990·Pharmacology, Biochemistry, and Behavior·L WardW C Abraham
Sep 1, 1997·Pharmacology, Biochemistry, and Behavior·H B LiH Watanabe
Dec 20, 2005·Current Opinion in Pharmacology·Keith W Muir
Jun 6, 2006·Proceedings of the National Academy of Sciences of the United States of America·Jeffrey J GoldLarry R Squire
Sep 6, 2007·Neuropsychology·David A GalloAndrew E Budson
Mar 21, 2009·Nitric Oxide : Biology and Chemistry·Li Zhou, Dong-Ya Zhu
Nov 3, 2010·Biological Psychiatry·Yanhui LiaoPaul C Fletcher
Jun 21, 2011·Expert Review of Clinical Pharmacology·Hong-Yi ZhouHui-Lin Pan
Dec 3, 2011·Pharmacology & Therapeutics·Marika V DoucetKumlesh K Dev
Feb 12, 2013·Current Biology : CB·Jonathon D CrystalAndrea G Hohmann
Mar 1, 2013·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Marika V DoucetAndrew Harkin
Sep 14, 2013·Current Biology : CB·Jonathon D Crystal, David L Glanzman
Mar 22, 2014·Biology Letters·Jonathon D Crystal, Wesley T Alford
Sep 27, 2014·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Gerard Sanacora, Alan F Schatzberg
Dec 4, 2014·Current Biology : CB·Jonathon D Crystal, Alexandra E Smith
Mar 15, 2015·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Gerard Sanacora, Alan F Schatzberg
Jun 14, 2015·Neuropharmacology·Wan-Hung LeeAndrea G Hohmann
Nov 27, 2015·Journal of the Experimental Analysis of Behavior·Jonathon D Crystal

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.